TERT and acute lymphoblastic leukemia: WRAP53 implication in leukemias was suggested by Nogueira et al. [82], in which the overexpression of TERT in patients with acute lymphoblastic leukemia (ALL) proved to be a common biomarker indifferent to the ALL subtype.